Cargando…

Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model

BACKGROUND: To compare tumor necrosis in hepatoma induced in rats by a single percutaneous injection of ethanol (PEI) or acetic acid (PAI). METHODS: BW7756 hepatomas of 1 mm(3 )were implanted in the liver of 40 male healthy rats. After 14 days, the 36 surviving rats were treated, in a single session...

Descripción completa

Detalles Bibliográficos
Autores principales: Zardi, Enrico M, Borzomati, Domenico, Cacciapaglia, Fabio, Picardi, Antonio, Valeri, Sergio, Bianchi, Antonella, Galeotti, Tommaso, Coppolino, Giusy, Coppola, Roberto, Afeltra, Antonella
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175504/
https://www.ncbi.nlm.nih.gov/pubmed/18078519
http://dx.doi.org/10.1186/1471-230X-7-45
_version_ 1782145473847492608
author Zardi, Enrico M
Borzomati, Domenico
Cacciapaglia, Fabio
Picardi, Antonio
Valeri, Sergio
Bianchi, Antonella
Galeotti, Tommaso
Coppolino, Giusy
Coppola, Roberto
Afeltra, Antonella
author_facet Zardi, Enrico M
Borzomati, Domenico
Cacciapaglia, Fabio
Picardi, Antonio
Valeri, Sergio
Bianchi, Antonella
Galeotti, Tommaso
Coppolino, Giusy
Coppola, Roberto
Afeltra, Antonella
author_sort Zardi, Enrico M
collection PubMed
description BACKGROUND: To compare tumor necrosis in hepatoma induced in rats by a single percutaneous injection of ethanol (PEI) or acetic acid (PAI). METHODS: BW7756 hepatomas of 1 mm(3 )were implanted in the liver of 40 male healthy rats. After 14 days, the 36 surviving rats were treated, in a single session, by ultrasound-guided injection of 300 μl of 95% ethanol (n = 17) or 100 μl of 50% acetic acid (n = 19). They were sacrificed 14 days after treatment and explanted tumoral livers were examined. The same PAI procedure was repeated on 13 additional rats to exclude a suspected occurrence of technical failures during the experiment, due to a surprisingly high rate of deaths within 30 minutes after PAI. RESULTS: Four rats died within four days after tumor implantation; after PEI, 1/17 (6%) died, whereas after PAI 9/19 (47%) died. The remaining 26 rats, after 14 days post-percutaneous ablation, were sacrificed. Gross and microscopic examinations showed that the hepatoma's nodules treated with PEI had 45.3 ± 19.4% tumor necrosis compared to 49 ± 23.3% (P = NS) for those treated with PAI. Complete tumor necrosis was not found in any animal. Peritoneal invasion was present in 4/16 (25%) and 2/10 (20%) rats treated with PEI or PAI, respectively (P = NS). Autopsy was performed in the 5 additional rats that died within 30 minutes after PAI. CONCLUSION: Our results show that there is no significant difference in the percentage of tumor necrosis between two local ablation methods in spite of the different dosages used. However, mortality in the PAI-treated group was greater than in PEI-treated group, presumably due to greater acetic acid systemic diffusion and its metabolic side effects. In human subjects, HCC occurs in the setting of cirrhosis, where the non-tumoral tissue is firmer than the tumor structure, with consequent reduction of drug diffusion. This could be the reason why some human studies have concluded similar or even better safety and efficacy with PAI compared to PEI.
format Text
id pubmed-2175504
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21755042008-01-08 Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model Zardi, Enrico M Borzomati, Domenico Cacciapaglia, Fabio Picardi, Antonio Valeri, Sergio Bianchi, Antonella Galeotti, Tommaso Coppolino, Giusy Coppola, Roberto Afeltra, Antonella BMC Gastroenterol Research Article BACKGROUND: To compare tumor necrosis in hepatoma induced in rats by a single percutaneous injection of ethanol (PEI) or acetic acid (PAI). METHODS: BW7756 hepatomas of 1 mm(3 )were implanted in the liver of 40 male healthy rats. After 14 days, the 36 surviving rats were treated, in a single session, by ultrasound-guided injection of 300 μl of 95% ethanol (n = 17) or 100 μl of 50% acetic acid (n = 19). They were sacrificed 14 days after treatment and explanted tumoral livers were examined. The same PAI procedure was repeated on 13 additional rats to exclude a suspected occurrence of technical failures during the experiment, due to a surprisingly high rate of deaths within 30 minutes after PAI. RESULTS: Four rats died within four days after tumor implantation; after PEI, 1/17 (6%) died, whereas after PAI 9/19 (47%) died. The remaining 26 rats, after 14 days post-percutaneous ablation, were sacrificed. Gross and microscopic examinations showed that the hepatoma's nodules treated with PEI had 45.3 ± 19.4% tumor necrosis compared to 49 ± 23.3% (P = NS) for those treated with PAI. Complete tumor necrosis was not found in any animal. Peritoneal invasion was present in 4/16 (25%) and 2/10 (20%) rats treated with PEI or PAI, respectively (P = NS). Autopsy was performed in the 5 additional rats that died within 30 minutes after PAI. CONCLUSION: Our results show that there is no significant difference in the percentage of tumor necrosis between two local ablation methods in spite of the different dosages used. However, mortality in the PAI-treated group was greater than in PEI-treated group, presumably due to greater acetic acid systemic diffusion and its metabolic side effects. In human subjects, HCC occurs in the setting of cirrhosis, where the non-tumoral tissue is firmer than the tumor structure, with consequent reduction of drug diffusion. This could be the reason why some human studies have concluded similar or even better safety and efficacy with PAI compared to PEI. BioMed Central 2007-12-13 /pmc/articles/PMC2175504/ /pubmed/18078519 http://dx.doi.org/10.1186/1471-230X-7-45 Text en Copyright © 2007 Zardi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zardi, Enrico M
Borzomati, Domenico
Cacciapaglia, Fabio
Picardi, Antonio
Valeri, Sergio
Bianchi, Antonella
Galeotti, Tommaso
Coppolino, Giusy
Coppola, Roberto
Afeltra, Antonella
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model
title Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model
title_full Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model
title_fullStr Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model
title_full_unstemmed Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model
title_short Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model
title_sort percutaneous ultrasound-guided ablation of bw7756-hepatoma using ethanol or acetic acid in a rat model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175504/
https://www.ncbi.nlm.nih.gov/pubmed/18078519
http://dx.doi.org/10.1186/1471-230X-7-45
work_keys_str_mv AT zardienricom percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT borzomatidomenico percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT cacciapagliafabio percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT picardiantonio percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT valerisergio percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT bianchiantonella percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT galeottitommaso percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT coppolinogiusy percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT coppolaroberto percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel
AT afeltraantonella percutaneousultrasoundguidedablationofbw7756hepatomausingethanoloraceticacidinaratmodel